CMR Surgical
Robotic system for minimal access surgery.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$20.0m | Series A | ||
$26.0m | Series A | ||
* | $100m | Series B | |
* | $240m Valuation: $1.0b | Series C | |
$600m Valuation: $3.0b | Series D | ||
* | $165m Valuation: $3.0b | Late VC | |
* | $100m | Debt | |
* | N/A | $100m Valuation: $3.0b | Late VC |
| Total Funding | $1.3b | ||
| GBP | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 1520 % | 167 % | 92 % | 29 % | 5 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | (12952 %) | (972 %) | (455 %) | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (14190 %) | (1084 %) | (518 %) | (426 %) | (265 %) | (249 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
CMR Surgical is a medical technology company that specializes in the development and distribution of surgical robots. Their primary product, Versius®, is a small, modular surgical robot designed to enhance the precision, dexterity, and versatility of minimal access surgery. This type of surgery is less invasive, resulting in quicker recovery times for patients. The company's target market includes hospitals and surgical teams looking to improve patient outcomes and drive efficiencies.
CMR Surgical operates in the healthcare technology market, specifically in the surgical robotics sector. Their business model revolves around selling Versius® to hospitals and clinics. The robot not only improves surgical outcomes but also collects actionable data and insights that can help hospitals improve their services. This data-driven approach is further strengthened by CMR Surgical's strategic collaboration with Ledidi, a Norwegian software company. Together, they are developing a platform to host CMR's clinical registry.
The company has also made significant strides in expanding its reach. For instance, a leading urology clinic in France has installed Versius® to accelerate its robotic surgery program. Furthermore, CMR Surgical has opened the only global surgical robotics manufacturing facility in the UK, strengthening the country's innovation ecosystem.
In summary, CMR Surgical is a pioneering company in the surgical robotics field, offering innovative solutions that enhance surgical precision and patient outcomes while driving efficiencies for healthcare providers.
Keywords: Surgical Robotics, Minimal Access Surgery, Healthcare Technology, Data-Driven, Versius®, Patient Outcomes, Surgical Precision, Innovation, CMR Surgical, Clinical Registry.